PharmExec Blog

Moving On + Up – 5/6/2010

By George Koroneos | Published: May 6, 2010
Ken Frazier

Ken Frazier

  • Merck upped Ken Frazier to president. He had been president of Global Human Health worldwide sales and marketing.
  • PharmAthene appointed Mitchel Sayare to its board.
  • Michael Marine joined the Sabine Vaccine Institute as CEO.
  • Interleukin Genetics added William Mills to its board.
  • Rigel Pharmaceuticals was named one of the recipients of the 2010 Innovators Award of Excellence by the San Mateo County Economic Development Association.
  • VIVUS appointed Michael Miller SVP and CCO.
  • Simbionix added Glen Mayfield and Raanan Cohen to its board.
  • PharmAthene’s board upped Eric Richman to interim CEO.
  • China Medicine appointed Fred Wai-Kuen Cheung its new CFO.
  • Chimerix promoted Kenneth Moch from COO to president and CEO and added him to its board. The company also named George Painter chief scientific officer and chairman of the board.
  • Genecor CEO Tjerk de Ruiter was elected chair of the industrial and environmental section of BIO, as well as its board.
  • Fran Dramis joined US Oncology’s board.

Reblog this post [with Zemanta]
Bookmark and Share
This entry was posted in People and tagged , , , , , , , . Bookmark the permalink. Trackbacks are closed, but you can post a comment.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>